Literature DB >> 6695594

Biochemical neuropathology of Parkinson's disease.

F Javoy-Agid, M Ruberg, H Taquet, B Bokobza, Y Agid, P Gaspar, B Berger, J N'Guyen-Legros, C Alvarez, F Gray.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6695594

Source DB:  PubMed          Journal:  Adv Neurol        ISSN： 0091-3952


× No keyword cloud information.
  20 in total

1.  Caudate nucleus pathology in Parkinson's disease: ultrastructural and biochemical findings in biopsy material.

Authors:  B Lach; D Grimes; B Benoit; A Minkiewicz-Janda
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

2.  Lewy bodies in the lower sacral parasympathetic neurons of a patient with Parkinson's disease.

Authors:  K Oyanagi; K Wakabayashi; E Ohama; S Takeda; Y Horikawa; T Morita; F Ikuta
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

Review 3.  Deterioration of dopaminergic pathways and alterations in cognition and motor functions.

Authors:  B Dubois; B Pillon; Y Agid
Journal:  J Neurol       Date:  1992       Impact factor: 4.849

4.  Constitutive and Acquired Serotonin Deficiency Alters Memory and Hippocampal Synaptic Plasticity.

Authors:  Sebastian P Fernandez; Aude Muzerelle; Sophie Scotto-Lomassese; Jacques Barik; Agnès Gruart; José M Delgado-García; Patricia Gaspar
Journal:  Neuropsychopharmacology       Date:  2016-07-27       Impact factor: 7.853

5.  Dementia in idiopathic Parkinson's disease. Variables associated with its occurrence in 203 patients.

Authors:  T S Elizan; H Sroka; H Maker; H Smith; M D Yahr
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

Review 6.  Mesencephalic and extramesencephalic dopaminergic systems in Parkinson's disease.

Authors:  Fanni F Geibl; Martin T Henrich; Wolfgang H Oertel
Journal:  J Neural Transm (Vienna)       Date:  2019-01-14       Impact factor: 3.575

7.  Influence of repeated levodopa administration on rabbit striatal serotonin metabolism, and comparison between striatal and CSF alterations.

Authors:  D A Loeffler; P A LeWitt; P L Juneau; D M Camp; A J DeMaggio; M K Havaich; P E Milbury; W R Matson
Journal:  Neurochem Res       Date:  1998-12       Impact factor: 3.996

Review 8.  Anti-parkinsonian drugs today.

Authors:  N P Quinn
Journal:  Drugs       Date:  1984-09       Impact factor: 9.546

9.  The Vulnerable Ventral Tegmental Area in Parkinson's Disease.

Authors:  Stephanie L Alberico; Martin D Cassell; Nandakumar S Narayanan
Journal:  Basal Ganglia       Date:  2015-08-01

10.  Motor and cognitive performances of parkinsonian patients in the on and off phases of the disease.

Authors:  F Girotti; F Carella; M P Grassi; P Soliveri; R Marano; T Caraceni
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-06       Impact factor: 10.154
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.